Comparative Effectiveness of Surgical Options for Patients with Ductal Carcinoma In Situ: An Instrumental Variable Approach
- 1 September 2018
- journal article
- Published by The Permanente Federation in The Permanente Journal
- Vol. 22 (3) , 17-132
Abstract
Many patients with ductal carcinoma in situ (DCIS) receive treatment that is too extensive. To take a holistic approach in comparing the effectiveness in cancer prevention between mastectomy and breast-conserving surgery (BCS) for patients with DCIS. Female Kaiser Permanente Southern California members who underwent surgery for treatment of single primary DCIS from 2004 to 2014 were identified by the Kaiser Permanente Southern California cancer registry and HealthConnect database. Two-stage residual inclusion with the surgeon's preference of surgical procedure type as the instrumental variable was used to examine the effect of surgical choice on DCIS recurrence, breast cancer progression, and other cancer progression. Traditional Cox proportional hazards models were used for comparison. Of qualified subjects, 72.2% underwent BCS and 27.8% underwent mastectomy. Patients were likelier to receive BCS if their surgeon preferred to perform BCS in the past 5 years (odds ratio = 1.02, 95% confidence interval = 1.02-1.03). Although traditional Cox proportional hazards models suggested an association between BCS and higher risk of DCIS recurrence, no significant effect was observed when we adjusted for endogeneity. Neither model showed significant differences between mastectomy and BCS in progression of any cancer. No significant benefit was observed with a more aggressive surgical procedure in preventing DCIS recurrence or cancer progression in a diverse population. Many patients with DCIS could benefit from BCS with preservation of their body image. Breast conservation followed-up with cancer surveillance is a rational approach to ensure affordable, effective care for patients with DCIS.Keywords
This publication has 45 references indexed in Scilit:
- Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In SituJAMA Oncology, 2015
- Progesterone receptor modulates ERα action in breast cancerNature, 2015
- Nationwide Trends in Mastectomy for Early-Stage Breast CancerJAMA Surgery, 2015
- Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS TrialJournal of Clinical Oncology, 2014
- Comparative Effectiveness of Ductal Carcinoma In Situ Management and the Roles of Margins and SurgeonsJNCI: Journal of the National Cancer Institute, 2011
- Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the BreastJournal of the National Cancer Institute Monographs, 2010
- Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and OutcomesJNCI: Journal of the National Cancer Institute, 2010
- Recent Trends in Breast Cancer Among Younger Women in the United StatesJNCI: Journal of the National Cancer Institute, 2008
- An Introduction To Instrumental Variables For epidemiologistsInternational Journal of Epidemiology, 2000
- The marginal benefits of invasive treatments for acute myocardial infarction: does insurance coverage matter?2000